StockIQ.techHaleon plc (HLN.L) Stock Analysis
Free AI-powered analysis and research for Haleon plc stock
Sector: Healthcare
HLN.L snapshot
Data as of 4 Nov 2026 close. Updated daily.
Haleon plc scores 33/100 on StockIQ's model, which reads as negative signals overall. The price is below its 200-day average and at 22% of its 52-week range, down 5.7% over the past year. Latest reported figures show a profit margin of 14.6%, return on equity of 10.1% and revenue growth of +2.2%.
What is driving the score
- RSI Neutral: +5
- Mixed Trend: +0
- MACD Bearish: -8
- Good Profit Margin (14.6%): +5
- Low Liquidity (0.69 Current Ratio): -10
- Below MA200: -4
- Underperforming (-5.7% over 1 year): -5
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full HLN.L report
Haleon plc (HLN.L) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze HLN.L Now →📰 Latest Update
Haleon margin reset and weak sales beyond oral care prompt Jefferies downgrade to 'hold'
Wed, November 4, 2026 at 12:30 PM UTC 4 min read
Haleon PLC (LSE:HLN, NYSE:HLN) has been downgraded by Jefferies to 'hold' from 'buy' due to a need for lower prices and increased marketing investment to boost sales growth outside of Oral Health. Jefferies cut its price target by 20% to 320p, citing a reduction in organic sales growth expectations for the year and challenges in the broader portfolio, particularly in European markets. The downgrade reflects concerns over the company's performance and future earnings potential.